RecallDepth
Class II Ongoing

Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
June 16, 2025
Posted
July 23, 2025
Recall Number
D-0516-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
5,448 bottles
Firm Location
Princeton, NJ, United States

Reason for Recall

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).

Distribution

Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.

Lot / Code Info

Lot # AD42648, Exp 02/28/2026

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class II Drug recalls